The Interactions of Anti-Cancer Drugs Approved in the Last Decade in the United States with Membrane Transporters

E-ISSN： 1875-5992|10|8|601-616

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.10, Iss.8, 2010-10, pp. : 601-616

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

COX-2 Polymorphism, Use of Nonsteroidal Anti-Inflammatory Drugs, and Risk of Colon Cancer in African Americans (United States)

By Sansbury Leah Millikan Robert Schroeder Jane North Kari Moorman Patricia Keku Temitope Cotret Allan Player Jon Sandler Robert

Cancer Causes and Control, Vol. 17, Iss. 3, 2006-04 ,pp. : 257-266

Springer Publishing Company

Access to resources Recommend Favorite

Herbal remedies in the United States: potential adverse interactions with anticancer agents

The Women's Oncology Review, Vol. 4, Iss. 3, 2004-09 ,pp. : 219-220

Informa Healthcare

Access to resources Recommend Favorite

Prescribing anti-cancer drugs in elderly cancer patients

By Monfardini S.

European Journal of Cancer, Vol. 38, Iss. 18, 2002-12 ,pp. : 2341-2346

Elsevier

Access to resources Recommend Favorite

The Role of FDA in the Regulation of Anti-Cancer Drugs

Current Cancer Therapy Reviews, Vol. 2, Iss. 4, 2006-11 ,pp. : 327-329

Bentham Science Publishers

Access to resources Recommend Favorite

DNA Helicases as Targets for Anti-Cancer Drugs

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 3, 2005-05 ,pp. : 183-199

Bentham Science Publishers

Access to resources Recommend Favorite